ARTICLE | Management Tracks
Weinhoff becomes CBO. Plus: QurAlis pads C-suite and updates from PepGen, C4 and more
By Richard Guy, Biopharma Analyst, and Jeff Cranmer, Executive Editor
June 12, 2024 12:46 AM UTC
Days after the completion of the takeout of his prior company, Fusion Pharmaceuticals Inc., John Crowley has become CFO of Centessa Pharmaceuticals plc (NASDAQ:CNTA). He succeeds Gregory Weinhoff, who takes on the newly created role of CBO. Crowley was CFO of Fusion until its $2 billion acquisition by AstraZeneca plc (LSE:AZN; NASDAQ:AZN).
Medicxi led the launch of Centessa with $250 million in February 2021 to take asset-centric companies further. The biotech, which is led by CEO Saurabh Saha, went public three months later in a $380 million IPO…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/652665/former-fusion-cfo-crowley-joins-centessa